Factors associated with serum high mobility group box 1 (HMGB1) levels in a general population

被引:43
作者
Fukami, Ako [1 ]
Adachi, Hisashi [1 ]
Yamagishi, Sho-ichi [2 ]
Matsui, Takanori [2 ]
Ueda, Shin-ichiro [1 ]
Nakamura, Kazuo [2 ]
Enomoto, Mika [1 ]
Otsuka, Maki [1 ]
Kumagae, Shun-ichi [1 ]
Nanjo, Yasuki [1 ]
Kumagai, Eita [1 ]
Esaki, Eishi [1 ]
Murayama, Kyoko [1 ]
Hirai, Yuji [1 ]
Imaizumi, Tsutomu [1 ]
机构
[1] Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Fukuoka 8300011, Japan
[2] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Fukuoka 8300011, Japan
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2009年 / 58卷 / 12期
关键词
GLYCATION END-PRODUCTS; SOLUBLE RECEPTOR; NEURITE OUTGROWTH; ENDOTHELIAL-CELLS; RAGE; SEPSIS; AMPHOTERIN; PROTEIN; ATHEROSCLEROSIS; DISEASE;
D O I
10.1016/j.metabol.2009.05.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High mobility group box 1 (HMGB1), a nonhistone chromatin-associated protein, is implicated as a mediator of both infectious and noninfectious inflammatory conditions. Clinical research on this protein in humans just has begun; serum HMGB1 was reported to be elevated in a small number of critically ill patients suffering from sepsis. However, the kinetics, distribution and factors associated with circulating HMGB1 are unknown in a general population. In this study, we examined these issues in a large population of healthy subjects. Fasting blood samples were obtained from 626 subjects (237 males and 389 females). HMGB1 levels showed a skewed distribution with a mean of 1.65 +/- 0.04 ng/ml. Multiple stepwise regression analyses found that white blood cell (WBC) counts (P = .016) and the soluble form of receptor for advanced glycation end products (sRAGE; P < .001, inversely), which is also known to be a receptor for HMGB1, were independently associated with HMGB1 levels. We demonstrated for the first time that circulating HMGB1 levels were inversely associated with sRAGE levels in a general population. Because RAGE is involved in HMGB1 signaling, our present study suggests that sRAGE may capture and eliminate circulating HMGB1 in humans. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:1688 / 1693
页数:6
相关论文
共 31 条
[1]  
Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084
[2]   High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes [J].
Andersson, U ;
Wang, HC ;
Palmblad, K ;
Aveberger, AC ;
Bloom, O ;
Erlandsson-Harris, H ;
Janson, A ;
Kokkola, R ;
Zhang, MH ;
Yang, H ;
Tracey, KJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (04) :565-570
[3]   Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications [J].
Basta, Giuseppina .
ATHEROSCLEROSIS, 2008, 196 (01) :9-21
[4]   High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD) [J].
Bruchfeld, Annette ;
Qureshi, Abdul Rashid ;
Lindholm, Bengt ;
Barany, Peter ;
Yang, LiHong ;
Stenvinkel, Peter ;
Tracey, Kevin J. .
MOLECULAR MEDICINE, 2008, 14 (3-4) :109-115
[5]   Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men [J].
Falcone, C ;
Emanuele, E ;
D'Angelo, A ;
Buzzi, MP ;
Belvito, C ;
Cuccia, M ;
Geroldi, D .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) :1032-1037
[6]   Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells [J].
Fiuza, C ;
Bustin, M ;
Talwar, S ;
Tropea, M ;
Gerstenberger, E ;
Shelhamer, JH ;
Suffredini, AF .
BLOOD, 2003, 101 (07) :2652-2660
[7]   High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis:: a prospective study [J].
Gaini, Shahin ;
Pedersen, Svend Stenvang ;
Koldkjær, Ole Græsboll ;
Pedersen, Court ;
Moller, Holger Jon .
CRITICAL CARE, 2007, 11 (02)
[8]   Soluble Receptor for Advanced Glycation End Products: From Disease Marker to Potential Therapeutic Target [J].
Geroldi, Diego ;
Falcone, Colomba ;
Emanuele, Enzo .
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (17) :1971-1978
[9]   Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia [J].
Goldstein, Richard S. ;
Gallowitsch-Puerta, Margot ;
Yang, LiHong ;
Rosas-Ballina, Mauricio ;
Huston, Jared M. ;
Czura, Christopher J. ;
Lee, David C. ;
Ward, Mae F. ;
Bruchfeld, Annette N. ;
Wang, Haichao ;
Lesser, Martin L. ;
Church, Adam L. ;
Litroff, Adam H. ;
Sama, Andrew E. ;
Tracey, Kevin J. .
SHOCK, 2006, 25 (06) :571-574
[10]   Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation [J].
Hatada, T ;
Wada, H ;
Nobori, T ;
Okabayashi, K ;
Maruyama, K ;
Abe, Y ;
Uemoto, S ;
Yamada, S ;
Maruyama, I .
THROMBOSIS AND HAEMOSTASIS, 2005, 94 (05) :975-979